76
|
Valeri M, Cieri M, Elefante GM, De Carlo C, Rudini N, Lughezzani G, Buffi NM, Terracciano LM, Colombo P. Case Report: Unclassified Renal Cell Carcinoma With Medullary Phenotype and SMARCB1/INI1 Deficiency, Broadening the Spectrum of Medullary Carcinoma. Front Med (Lausanne) 2022; 9:835599. [PMID: 35198580 PMCID: PMC8858824 DOI: 10.3389/fmed.2022.835599] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2021] [Accepted: 01/10/2022] [Indexed: 11/13/2022] Open
Abstract
Renal medullary carcinoma (RMC) is a rare entity with poor prognosis bearing inactivating genomic alterations in SMARCB1/INI1 resulting in the loss of expression of INI1 and occurring in young patients with sickle cell trait or sickle cell disease. Recently, rare examples with histological characteristics of RMC have been described in older patients without hemoglobinopathies and provisionally termed “Renal cell carcinoma unclassified with medullary phenotype” (RCCU-MP). Fluorescence in situ Hybridization (FISH) can detect alterations in SMARCB1/INI1 consisting mostly in inactivating translocation of one allele and deletion of the second. To date, only seven further cases of RCCU-MP have been described in the literature. Here we report the second Italian case of RCCU-MP, a 62-year-old man presenting with persistent dull back pain and incidentally discovering a 13 cm mass in the right kidney. The nomenclature of this entity is still debated and might be updated as a variant of medullary carcinoma in the upcoming WHO classification. In the meantime, we encourage awareness of these extraordinarily rare neoplasms with poor outcomes.
Collapse
|
77
|
Frego N, Contieri R, Maffei D, Fasulo V, Uleri A, Beatrici E, Diana P, Lazzeri M, Saita A, Lughezzani G, Buffi N, Casale P, Hurle R. Prognostic risk factors of grade and stage migration in patients under active surveillance: A prospective cohort study from Bladder cancer Italian Active Surveillance register (BIAS). Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00314-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
78
|
Frego N, Paciotti M, Avolio P, Maffei D, Contieri R, Uleri A, Lazzeri M, Saita A, Casale P, Buffi N, Lughezzani G. External validation and comparison of two nomograms predicting the probability of lymph node involvement in patients subjected to robotic radical prostatectomy and concomitant lymph node dissection. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00738-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
79
|
Cieri M, Belsito V, Bressan A, Valeri M, De Carlo C, Lughezzani G, Terracciano L, Colombo P. Unexpected low metastatic potential to lymph-nodes of isolated tumor cell and cluster-cord in ISUP 5 prostate adenocarcinoma: A mono-institutional cohort analysis with clinic-pathological correlation. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00906-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
80
|
Lazzeri M, Chiarelli G, Corbetta M, Asselta R, De Simone I, Soldà G, Duga S, Zuradelli M, Casale P, Saita A, Lughezzani G, Guazzoni G, Hurle R, Benetti A, Saitta C, Fasulo V, Buffi N. Post-biopsy cell-free DNA from blood in primary prostate cancer: How to get genetics data for decision making. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00573-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
81
|
Chiarelli G, Fasulo V, Zuradelli M, Buffi N, Lughezzani G, Guazzoni G, Ripamonti C, Benetti A, Casale P, Saita A, Hurle R, Avolio P, Lazzeri M. Awareness of risk of prostate cancer (PCa) remains poor in families with germline mutations in DNA-repair genes. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00439-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
82
|
Maffei D, Avolio P, Saitta C, Paciotti M, Fasulo V, Beatrici E, Giuseppe C, Lazzeri M, Saita A, Hurle R, Guazzoni G, Casale P, Buffi N, Lughezzani G. Diagnostic performance of micro-ultrasound guided reclassification biopsies in patients under active surveillance for prostate cancer. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00829-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
83
|
Beatrici E, Contieri R, Frego N, Fasulo V, Diana P, Paciotti M, Saitta C, Chiarelli G, Arena P, Gobbo A, Avolio P, Uleri A, Buffi N, Lazzeri M, Casale P, Saita A, Guazzoni G, Lughezzani G, Hurle R. The update from Bladder Cancer Italian Active Surveillance (BIAS) project for low-grade bladder tumors: Long-term oncological outcomes of patients under active surveillance. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00313-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
84
|
Hurle R, Gobbo A, Casale P, Saita A, Buffi N, Lughezzani G, Sollini M, Rodari M, Pini C, Gelardi F, Contieri R, Guazzoni G, Chiti A, Lazzeri M. [18F]-FDG PET/CT for bladder cancer staging and decision-making in patients with High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC). Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00316-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
85
|
Uleri A, Diana P, Beatrici E, Lughezzani G, Poretti D, D'Antuono F, Lazzeri M, Hurle R, Saita A, Casale P, Contieri R, Fasulo V, Pedicini V, Buffi N. Developing of a novel nephrometry score to predict the outcomes of percutaneous ablation of renal masses: The PCT score. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00301-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
86
|
Avolio P, Fasulo V, Paciotti M, Frego N, Diana P, Maffei D, Contieri R, Uleri A, Beatrici E, Saitta C, Saita A, Lazzeri M, Hurle R, Casale P, Buffi N, Lughezzani G. Assessing the role of high-resolution micro-ultrasound among patients with a negative multiparametric MRI and a persistent suspicion of prostate cancer. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00831-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
87
|
Contieri R, Gobbo A, Paciotti M, Avolio P, Fasulo V, Saitta C, Uleri A, Valeri M, Colombo P, Saita A, Lazzeri M, Casale P, Lughezzani G, Buffi N, Guazzoni G, Hurle R. Accuracy of AUA and EAU risk stratification groups in predicting early recurrence in Hg Ta non-muscle invasive bladder cancer: A comparison analysis. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00320-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
88
|
Fasulo V, Buffi NM, Regis F, Paciotti M, Persico F, Maffei D, Uleri A, Saita A, Casale P, Hurle R, Lazzeri M, Guazzoni G, Lughezzani G. Use of high-resolution micro-ultrasound to predict extraprostatic extension of prostate cancer prior to surgery: a prospective single-institutional study. World J Urol 2022; 40:435-442. [PMID: 35001161 DOI: 10.1007/s00345-021-03890-4] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2021] [Accepted: 11/13/2021] [Indexed: 11/24/2022] Open
Abstract
PURPOSE We aim to evaluate the accuracy of micro-ultrasound (microUS) in predicting extraprostatic extension (EPE) of Prostate Cancer (PCa) prior to surgery. METHODS Patients with biopsy-proven PCa scheduled for robot-assisted radical prostatectomy (RARP) were prospectively recruited. The following MRI-derived microUS features were evaluated: capsular bulging, visible breach of the prostate capsule (visible extracapsular extension; ECE), presence of hypoechoic halo, and obliteration of the vesicle-prostatic angle. The ability of each feature to predict EPE was determined. RESULTS Overall, data from 140 patients were examined. All predictors were associated with non-organ-confined disease (p < 0.001). Final pathology showed that 79 patients (56.4%) had a pT2 disease and 61 (43.3%) ≥ pT3. Rate of non-organ-confined disease increased from 44% in those individuals with only 1 predictor (OR 7.71) to 92.3% in those where 4 predictors (OR 72.00) were simultaneously observed. The multivariate logistic regression model including clinical parameters showed an area under the curve (AUC) of 82.3% as compared to an AUC of 87.6% for the model including both clinical and microUS parameters. Presence of ECE at microUS predicted EPE with a sensitivity of 72.1% and a specificity of 88%, a negative predictive value of 80.5% and positive predictive value of 83.0%, with an AUC of 80.4%. CONCLUSIONS MicroUS can accurately predict EPE at the final pathology report in patients scheduled for RARP.
Collapse
|
89
|
Maffei D, Paciotti M, Avolio P, Frego N, Diana P, Fasulo V, Uleri A, Contieri R, Hurle R, Lazzeri M, Saita A, Casale P, Guazzoni G, Buffi N, Lughezzani G. Prostate biopsies by micro-ultrasound for clinically significant cancer detection: Results from a high-volume center. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)03095-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
90
|
Paciotti M, Fasulo V, Lazzeri M, Contieri R, Casale P, Avolio P, Saita A, Lughezzani G, Diana P, Frego N, Saitta C, Guazzoni G, Buffi N, Hurle R. Xpert bladder monitor may avoid cystoscopies in patients under “active surveillance” for recurrent bladder cancer (BIAS project): longitudinal cohort study. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00936-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
91
|
Contieri R, Frego N, Paciotti M, Diana P, Beatrici E, Avolio P, Uleri A, Fasulo V, Saita A, Casale P, Buffi N, Lughezzani G, Lazzeri M, Guazzoni G, Hurle R. Active surveillance in low-grade non-muscle-invasive bladder cancers. Results after 8 years of bladder cancer Italian Active Surveillance (BIAS) project. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00703-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
92
|
Arena P, Paciotti M, Maffei D, Matassa G, Jandric J, Fasulo V, Gobbo A, Frego N, Beatrici E, Hurle R, Saita A, Casale P, Lazzeri M, Lughezzani G, Guazzoni G, Chiti A, Buffi N. Additional value of 68GA-PSMA PET in patients who underwent choline-pet for biochemical recurrence after radical treatment for prostate cancer. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00970-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
93
|
Contieri R, Paciotti M, Frego N, Maffei D, Avolio P, Diana P, Uleri A, Fasulo V, Domanico L, Gobbo A, Lazzeri M, Saita A, Taverna G, Greco F, Muto G, Barra S, Casale P, Lughezzani G, Buffi N, Guazzoni G, Hurle R. Is it safe to replace retur in T1 high grade non-muscle invasive bladder cancer patients with urine cytology and in-office cystoscopy? Preliminary results from the ongoing prospective multicenter trial “hunire”. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00941-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
94
|
Frego N, Avolio P, Paciotti M, Diana P, Contieri R, Uleri A, Maffei D, Fasulo V, Saita A, Buffi N, Casale P, Lughezzani G. One-year follow-up results following transperineal laser ablation for the treatment of benign prostatic hyperplasia: a single institutional experience. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00712-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
95
|
Taverna G, Thiel LM, Miller DL, Tidu L, Sardella P, Camp P, Zanoni ML, Vota P, Mazzieri C, Toia G, Fasulo V, Avolio P, Benetti A, Buffi N, Lughezzani G, Lazzeri M, Casale P, Guazzoni G, Grizzi F, Stork B. Hope for Ostomates: A Carbon and Zeolite Impregnated Polyester Fabric Inhibits Urine Odor in Cancer Patients: A Randomized Experimental Study. Asian Pac J Cancer Prev 2021; 22:2917-2921. [PMID: 34582662 PMCID: PMC8850874 DOI: 10.31557/apjcp.2021.22.9.2917] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2021] [Indexed: 11/25/2022] Open
Abstract
OBJECTIVE Many individuals with bladder cancer have undergone a surgical urostomy and often complain of being self-conscious of the unpleasant smell of their own urine. The focus of this study was to test the efficacy of a pouch cover made of a carbon and zeolite containing polyester material to inhibit the smell of urine by comparing two trained dogs' response time in detecting volatile organic compounds (VOCs) in urine, with and without the fabric covering the samples. METHODS This study used a randomized, blinded experimental design to evaluate the efficacy of a fabric to interfere with two highly trained dogs' ability to detect specific VOCs present in the urine of prostate cancer patient. Ninety urine samples were analyzed in this study. RESULTS Prior to the experiment, both dogs accurately detected VOCs in the uncovered test urine samples of men with prostate cancer with a sensitivity and specificity of nearly 100%. Both dogs recognized the "uncovered" urine samples of men with prostate cancer within two seconds. When the test sample was covered with the study fabric, the test urine samples were detected within 30-40 seconds and in some instances the dogs were not able to identify the covered samples, whatsoever. CONCLUSION The findings of this study demonstrate that the carbon and zeolite containing polyester fabric did significantly interfere with the ability of the dogs to detect VOCs in urine of men with prostate cancer. The fabric may show promise as a pouch cover in controlling offensive urine odor which many ostomates experience.
Collapse
|
96
|
Uleri A, Hurle R, Contieri R, Diana P, Buffi N, Lazzeri M, Saita A, Casale P, Guazzoni G, Lughezzani G. Combination of AST to ALT and neutrophils to lymphocytes ratios as predictors of locally advanced disease in patients with bladder cancer subjected to radical cystectomy: Results from a single-institutional series. Urologia 2021; 89:363-370. [PMID: 34346247 DOI: 10.1177/03915603211035191] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND Bladder cancer (BC) staging is challenging. There is an important need for available and affordable predictors to assess, in combination with imaging, the presence of locally-advanced disease. OBJECTIVE To determine the role of the De Ritis ratio (DRR) and neutrophils to lymphocytes ratio (NLR) in the prediction of locally-advanced disease defined as the presence of extravescical extension (pT ⩾ 3) and/or lymph node metastases (LNM) in patients with BC treated with radical cystectomy (RC). METHODS We retrospectively analyzed clinical and pathological data of 139 consecutive patients who underwent RC at our institution. Logistic regression models (LRMs) were fitted to test the above-mentioned outcomes. RESULTS A total of 139 consecutive patients underwent RC at our institution. Eighty-six (61.9%) patients had a locally-advanced disease. NLR (2.53 and 3.07; p = 0.005) and DRR (1 and 1.17; p = 0.01) were significantly higher in patients with locally-advanced disease as compared to organ-confined disease. In multivariable LRMs, an increasing DRR was an independent predictor of locally-advanced disease (OR = 3.91; 95% CI: 1.282-11.916; p = 0.017). Similarly, an increasing NLR was independently related to presence of locally-advanced disease (OR = 1.28; 95% CI: 1.027-1.591; p = 0.028). In univariate LRMs, patients with DRR > 1.21 had a higher risk of locally advanced disease (OR = 2.83; 95% CI: 1.312-6.128; p = 0.008). Similarly, in patients with NLR > 3.47 there was an increased risk of locally advanced disease (OR = 3.02; 95% CI: 1.374-6.651; p = 0.006). In multivariable LRMs, a DRR > 1.21 was an independent predictor of locally advanced disease (OR = 2.66; 95% CI: 1.12-6.35; p = 0.027). Similarly, an NLR > 3.47 was independently related to presence of locally advanced disease (OR = 2.24; 95% CI: 0.95-5.25; p = 0.065). No other covariates such as gender, BMI, neoadjuvant chemotherapy or diabetes reached statistical significance. The AUC of the multivariate LRM to assess the risk of locally advanced disease was 0.707 (95% CI: 0.623-0.795). Limitations include the retrospective nature of the study and the relatively small sample size.
Collapse
|
97
|
Paciotti M, Contieri R, Fasulo V, Casale P, Saita A, Buffi NM, Lughezzani G, Diana P, Frego N, Guazzoni G, Lazzeri M, Hurle R. Active surveillance for recurrent Non-Muscle Invasive Bladder Cancer (NMIBC): which lessons have we learned during COVID-19 pandemia? Minerva Urol Nephrol 2021; 74:1-4. [PMID: 34338493 DOI: 10.23736/s2724-6051.21.04613-9] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
98
|
Uleri A, Diana P, Lughezzani G, Lazzeri M, Casale P, Porpiglia F, Amparore D, Verri P, Rosiello G, Mottrie A, De Naeyerd G, De Grooted R, Porter J, Buffi N. Robot-assisted partial nephrectomy for ruptured angiomyolipomas: A multi institutional series. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01635-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
99
|
Paciotti M, Yim K, Nguyen D, Marchese M, Häuser L, Modonutti D, Kölker M, Lughezzani G, Buffi N, Mossanen M, Trinh QD, Cole A. Propensity score based comparison of nephroureterectomy versus segmental ureterectomy for ureteral tumors. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01178-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
100
|
Maffei D, Paciotti M, Avolio P, Frego N, Fasulo V, Diana P, Contieri R, Uleri A, Lazzeri M, Hurle R, Saita A, Casale P, Guazzoni G, Buffi N, Lughezzani G. Diagnostic accuracy of mpMRI-US fusion and micro-ultrasound guided biopsies for clinically significant prostate cancer detection. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01300-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|